Cannara Biotech8CB0 
$0.44-5.66%24h
-5.66%24h
Global rank26472
Market cap$39.70M
Change 7d-5.21%
YTD Performance-27.93%
SP500 benchmarkUnderperform
P/E5.56
P/S0.94
Revenue$42.06M
Earnings$5.10M
Dividend yield-
Main Sector
Healthcare
Cannara Biotech 8CB0 Total Debt
8CB0 Total Debt in 2022: $29.19M
According to Cannara Biotech latest financial reports the total debt is $29.19M, an decrease of -13.99% to 2022. At the end of 2022 company had $33.94M total debt. This figure represents the debts and financial obligations that Cannara Biotech combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Cannara Biotech 8CB0 Total Debt History from 2023 to 2022
-
Value:-
8CB0 Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $29.19M | -13.99% |
| 2022 | $33.94M | 126.85% |
| 2021 | $14.96M | 63.94% |
| 2020 | $9.13M | -5.05% |
| 2019 | $9.61M | - |
View the Top Total Debt Stocks 
